Biomea Fusion's Latest Chapter: Unpacking the Nuances of a Pivotal Quarter
A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World
Alto Neuroscience's Breakthrough: Schizophrenia Drug ALTO-301 Rockets Towards Approval with FDA Fast Track!
Life-Changing Breakthrough: Cystic Fibrosis Drug Earns Developers Prestigious "American Nobel" for Decades of Extended Life
Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion